Financial Statements · Financial Reporting
Pharma Nord Eesti OÜ
Official identifier 14194775Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 20 May 2026
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 128,589 |
| Balance sheet | Cash and cash equivalents | 2,689 |
| Balance sheet | Current assets | 125,302 |
| Balance sheet | Current liabilities | 79,936 |
| Balance sheet | Equity | 48,653 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 3,287 |
| Balance sheet | Retained earnings (loss) from previous periods | 13,218 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -2,669 |
| Income statement scheme 1 | Labour costs | -296,203 |
| Income statement scheme 1 | Revenue | 780,813 |
| Income statement scheme 1 | Annual period profit / loss | 32,935 |
| Income statement scheme 1 | Operating profit (loss) | 49,286 |
| Income statement scheme 1 | Profit (loss) before income tax | 42,425 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 13,218 |
| Note: Labour costs | Employees | 7 |
| Note: Labour costs | Labour costs | 296,203 |
Linked company
Company: Pharma Nord Eesti OÜ